EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design

Grazia Raffaella Tundo, Giuseppe Grasso iD, Marco Persico iD, Oleh Tkachuk, Francesco Bellia iD, Alessio Bocedi, Stefano Marini, Mariacristina Parravano, Grazia Graziani iD, Caterina Fattorusso iD, Diego Sbardella

Biomolecules · 07.10.2023 · 13 (10) · 1492

DOI: 10.3390/biom13101492 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.10.2023. Verfasst von Grazia Raffaella Tundo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Traslational Medicine, University of Rome Tor Vergata, Via Della Ricerca Scientifica 1, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Insulysin, Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: protocol no. A0375-2020-36583- Public Notice “Research groups 2020”—POR FESR Lazio 2014-2020—Action 1.2.1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The insulin-degrading enzyme (IDE) is a Zn2+ peptidase originally discovered as the main enzyme involved in the degradation of insulin and other amyloidogenic peptides, such as the β-amyloid (Aβ) peptide. Therefore, a role for the IDE in the cure of diabetes and Alzheimer’s disease (AD) has been long envisaged. Anyway, its role in degrading amyloidogenic proteins remains not clearly defined and, more recently, novel non-proteolytic functions of the IDE have been proposed. From a structural point of view, the IDE presents an atypical clamshell structure, underscoring unique enigmatic enzymological properties. A better understanding of the structure–function relationship may contribute to solving some existing paradoxes of IDE biology and, in light of its multifunctional activity, might lead to novel therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulysinAlzheimer DiseaseHumansAmyloid beta-PeptidesAmyloidogenic ProteinsDrug Design

Stichwörter der Autor:innen

Alzheimer’s diseaseallosterydiabetesinsulininsulin-degrading enzymeproteasome

Substanzen

InsulysinAmyloid beta-PeptidesAmyloidogenic Proteins

Autor:innen und Institutionen

  • Department of Clinical Science and Traslational Medicine, University of Rome Tor Vergata, Via Della Ricerca Scientifica 1, 00133 Rome, Italy.
  • Department of Chemical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
  • Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Napoli, Italy.
  • Institute of Crystallography, CNR, Via Paolo Gaifami 18, 95126 Catania, Italy.
  • Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.
  • IRCCS-Fondazione Bietti, Rome, Italy.

ORCID-Profile: Giuseppe Grasso, Marco Persico, Francesco Bellia, Grazia Graziani, Caterina Fattorusso

Förderung

  • protocol no. A0375-2020-36583- Public Notice “Research groups 2020”—POR FESR Lazio 2014-2020—Action 1.2.1

Zitieren

APA

Tundo, G. R., Grasso, G., Persico, M., Tkachuk, O., Bellia, F., Bocedi, A., Marini, S., Parravano, M., Graziani, G., Fattorusso, C., & Sbardella, D. (2023). The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Biomolecules, 13(10), 1492. https://doi.org/10.3390/biom13101492

Vancouver

Tundo GR, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A, et al. The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Biomolecules. 2023;13(10):1492. doi:10.3390/biom13101492

BibTeX
@article{Tundo2023,
  author = {Tundo, Grazia Raffaella and Grasso, Giuseppe and Persico, Marco and Tkachuk, Oleh and Bellia, Francesco and Bocedi, Alessio and Marini, Stefano and Parravano, Mariacristina and Graziani, Grazia and Fattorusso, Caterina and Sbardella, Diego},
  title = {The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {10},
  pages = {1492},
  doi = {10.3390/biom13101492}
}
Kostenlos starten →